Novel mode of action of the calcium antagonist mibefradil (Ro 40‐5967): potent immunosuppression by inhibition of T‐cell infiltration through allogeneic endothelium-Reference-Cited by-同舟云学术

Novel mode of action of the calcium antagonist mibefradil (Ro 40‐5967): potent immunosuppression by inhibition of T‐cell infiltration through allogeneic endothelium

Published:1998-06-14 Issue:2 Volume:94 Page:213-220
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Blaheta R. A.¹,Hailer N. P.²,Brude N.¹,Wittig B.³,Oppermann E.¹,Leckel K.¹,Harder S.⁴,Scholz M.⁵,Weber S.¹,Encke A.¹,Markus B. H.¹

Affiliation:

1. *General Surgery,

2. Department of Anatomy, University Hospital Charité, Berlin,

3. German Cancer Institute, Heidelberg, Germany

4. Clinical Pharmacology,

5. Medical Virology, Johann Wolfgang Goethe‐University, Frankfurt am Main,

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2567.1998.00504.x

Reference37 articles.

1. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts

2. Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension

3. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40–5967), a novel calcium antagonist.;Petrie J.R.;J Hypertens,1995

4. Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: A multicenter placebo-controlled study

5. Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: A multicenter, placebo-controlled study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on Voltage-gated Calcium Channels and Their Functions in Endothelial Cells;PROG BIOCHEM BIOPHYS;2022

2. Antihypertensives and melanoma: An updated review;Pigment Cell & Melanoma Research;2020-08-16

3. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer;BMC Cancer;2019-06-24

4. Epigenetic, Genetic, and Acquired Regulation of Cav3 T-Type Calcium Channel Expression and Function in Tumor Growth and Progression;Pathologies of Calcium Channels;2013-11-09

5. Facilitation of Ca2+-activated K+ channels (IKCa1) by mibefradil in B lymphocytes;Pflügers Archiv - European Journal of Physiology;2008-01-08